1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 4-aminopyridine in 3 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (4-aminopyridine) | Trials (4-aminopyridine) | Recent Studies (post-2010) (4-aminopyridine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 4,141 | 134 | 804 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braquet, P; Kecskemeti, V | 1 |
| Eigendorf, GK; Salari, H | 1 |
| Balogh, I; Kecskeméti, V | 1 |
3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 4-aminopyridine
| Article | Year |
|---|---|
Cellular electrophysiological effects of platelet-activating factor (PAF) and its antagonist BN 52021 in cardiac preparations.
Topics: 4-Aminopyridine; Action Potentials; Animals; Calcium; Diterpenes; Dose-Response Relationship, Drug; Ginkgolides; Guinea Pigs; Lactones; Membrane Potentials; Papillary Muscles; Platelet Activating Factor; Potassium Channels | 1992 |
Detection of lyso-platelet-activating factor by high-performance liquid chromatography after derivatisation with fluorescent fatty acids.
Topics: 4-Aminopyridine; Animals; Anthracenes; Benzenesulfonates; Chromatography, High Pressure Liquid; Dicyclohexylcarbodiimide; Fluorescent Dyes; Indicators and Reagents; Mass Spectrometry; Platelet Activating Factor; Rabbits | 1990 |
The role of platelet-activating factor (PAF) antagonists and nitric oxide in cardiac actions of PAF. Electrophysiological and morphological study.
Topics: 4-Aminopyridine; Action Potentials; Animals; Azepines; Diterpenes; Electrophysiology; Fibrinolytic Agents; Ginkgolides; Glyburide; Guinea Pigs; Heart; In Vitro Techniques; Lactones; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Platelet Activating Factor; Platelet Aggregation Inhibitors; Potassium Channel Blockers; Reperfusion Injury; Triazoles | 2000 |